Dopaminergic ligands labeled with positron emitting radionuclides have been synthesized for quanti tative evaluation of dopaminergic binding in vivo. Two different methods, the explicit method and an operation ally simplified ratio method , have been proposed for anal ysis of these positron emission tomographic (PET) data.
Until recently, investigation of diseases in humans thought to involve dopaminergic receptors has been limited to postmortem studies. A method for quantitative measurement of dopaminergic binding in vivo would be of great value in eluci dating the role of dopaminergic receptors in the pathogenesis of these diseases and in defining the alterations induced by their pharmacological treat ment.
Numerous investigators have synthesized dopa minergic ligands labeled with positron-emitting ra dionucJides for the measurement of dopaminergic binding in vivo using positron emission tomography (PET) (Tewson et al ., 1980; Wagner et al ., 1983;  method for the specific rate constant describing receptor binding varied depending upon the time after tracer injec tion , thus demonstrating an internal inconsistency in this approach. Tracer metabolism markedly affected the binding measurements calculated with either method and thus cannot be ignored. Our results indicate that the adoption of simplifying assumptions for operational con venience can lead to substantial errors and must be done with caution. Alternatively, we present simple new ana lytical solutions of the tracer conservation equations de scribing the complete , unsimplified three-compartment model that vastly reduce the computations necessary to implement the explicit method. Key Words: Dopamine Metabolism-Modeling-Positron emission tomog raphy-Receptors. Kilbourn et al ., 1984; Mintun et al ., 1984; Arnett et al ., 1985; Baron et al., 1985) . The requirements of desirable radiopharmaceuticals for these studies have been reviewed recently (Arnett et al., 1985) . The most important of these is that the ligand have a relatively higher degree of binding to specific re ceptor sites in vivo than to nonspecific nonreceptor sites. In vivo studies suggest that the labeled dopa minergic ligands [ISF] spiroperidol and [ l IC]N-meth ylspiroperidol are superior to others such as [ l IC]pimozide and [1sF]haloperidol in this regard (Welch et al ., 1983; Arnett et al., 1985; Baron et al ., 1985) . PET images obtained 30-60 min after the in travenous injection of these radiotracers show re gional radioactivity distributions similar to the known distribution of dopaminergic receptors in the brain. Areas known to have high concentrations of dopaminergic receptors (e.g., striatum) accumu late a higher concentration of tracer than areas known to be devoid of dopaminergic receptors (e. g., cerebellum) (Kuhar et aI ., 1978; Laduron et aI., 1978) . Although these images appear to show evidence of specific binding, direct quantitative measurements of dopaminergic binding cannot be made from the regional radioactivity distribution alone. Other factors such as regional tracer de livery, intravascular content of tracer, nonspecific binding, and the presence of any labeled metabo lites of the tracer must be taken into account. Two different methods for analysis of PET data allowing quantitative evaluation of dopaminergic binding in vivo have been proposed (Mintun et ai., 1984; Wong et ai ., 1984) . Both utilize the same basic t?ree-compartment model but diffe r in the assump tIOns made to simplify the modeling equations. One method, the explicit method (Mintun et aI ., 1984) , utilizes single measurements of regional cerebral blood flow and blood volume fo llowed by sequen tial PET scans and measurements of arterial blood radioactivity for at least 2 h after intravenous injec tion of [IBFJspiroperidoi. An alternative method the ratio method (Wong et ai. , 1984) , also require� sequential PET scans and measurements of arterial blood radioactivity for 45-60 min after the intrave nous injection of [IICJN-methylspiroperidol, but does not utilize separate measurements of regional blood flow and blood volume. Calculation of re gional binding is based on assumptions leading to a simple computational scheme that uses the ratio of striatal to cerebellar tissue radioactivities. The ex plicit method of Mintun et al . (1984) does not use simplifying assumptions; rather these authors solve the ordinary fi rst-order differential equations of their model with a numerical integration scheme that is computationally slow.
In this article, we introduce an algorithm that is relatively efficient and is based on easily derived analytical solutions for the relevant differential equations. We use these analytical solutions for es timating the parameters of the explicit method (Mintun et aI ., 1984) . We give our analytical solu tion of the relevant three-compartment model equations in Appendix A. Using the same symbols and nomenclature to facilitate intercomparison of the two methods, we review the derivations of Wong et aI. (1984) in Appendix B. We summarize in Appendix C the different notations employed by Mintun et al. and by Wong et aI ., and show the re lationship of these notations to each other and to the conventional notation of compartmental anal ysis, which we henceforth advocate in the interest of clarity. We compare the performance of the ex plicit and ratio methods by applying each method to the same data obtained in our laboratory from se quential PET scans and arterial blood samples of a baboon fo llowing intravenous injection of [IBFJspi roperidol.
THEORY Three-compartment model
We will describe first the three-compartment model that fo rms the basis for both the explicit and the ratio method. The assumptions of this model in clude the fo llowing: After intravenous injection, ra diolabeled ligand is distributed within the intravas cular space as free tracer and as tracer bound to nonspecific sites in plasma (specific binding sites in the intravascular compartment also may exist but are ignored here) . Unbound ligand is free to cross the blood-brain barrier (BBB) and enter the cere bral extravascular space. Within the extravascular space, ligand can be free, nonspecifically bound, or specifi cally bound to saturable sites (i.e., to re ceptors). This is the basis of the three-compartment model shown in Fig. 1 . More precisely, five com partments have been described. Since association dissociation kinetic rate constants for nonspecific binding are assumed to be much larger than the compartmental rate constants , the free and the nonspecifically bound moieties on either side of the BBB can be viewed as a single compartment. In FIG. 1 . Three-compartment model as applied to receptor binding is shown. Compartment 1 represents the intravas cular space; compartment 2, the free and nonspecifically bound tracer within the cerebral extravascular space; and compartment 3, the specific binding sites within the extra vascular space. Together these compartments contain all ra diotracer within the field of view of the positron emission tomograph (PET). Directions of the passage of tracer into and out of the field of view as well as its movements between compartments are indicated by the arrows. Following con ventional usage, the turnover rate constants k; denote frac tions of radiotracer in compartments j that �ove per unit time into compartments i. Zero subscript denotes the sur roundings external to all compartments and to the PET re gion of interest. Tracer enters the field of view of the PET via flowing blood. qi is the quantity of radiotracer in compart ment i and Vi is the volume of that compartment. Explicit and ratio methods are based upon this three-compartment model. this manner, the five compartments have been col lapsed to three . Each compartment corresponds to a volume in which radiotracer can distribute or, al ternatively, to a biochemical state in which it can exist. Compartment 1 represents the intravascular space ; compartment 2, the free and nonspecifi cally bound tracer within the cerebral extravascular space; and compartment 3, the specific binding sites within the extravascular space. To gether these compartments comprise all radiotracer within the fi eld of view of the PET. The directions of the pas sage of tracer into and out of the field of view as well as of its movements between compartments are indicated by the arrows in Fig. 1 . Following conventional usage , the turnover rate constants kij denote fractions of radio tracer in compartments j that move per unit time into compartments i. A zero subscript denotes the surroundings external to all compartments and to the PET region of interest. Labeled metabolites of the tracer also can enter and leave the region of interest via flowing blood and are detected with the same efficiency as the unme tabolized tracer.
After the compartments and relevant parameters have been identified (Table 1) , mathematical equa tions are fo rmulated that describe the time-de pendent tracer conservation conditions. Since dis appearance of tracer due to radioactive decay is not accounted for in the conservation equations, the PET data must be decay corrected before they are processed. This fo rmulation for the three-compart ment model results in differential equation set A2 (Appendix A) . The differential equations can be in tegrated analytically or numerically ; the integrated equations express the time-dependent radiotracer content within each compartment in terms of the modeling parameters . Pa rameter estimation schemes then can be employed using these solu tions to calculate the best estimates of the modeling parameters from the data. The two methods dis cussed in this article diffe r in the assumptions made to simplify the modeling equations , and each method has its own set of variables and parameters . The two sets of variables and parameters are de fi ned and compared in Ta ble I.
Explicit method. The explicit method for the measurement of [IXF]spiroperidol binding in vivo has been described in detail (Mintun et aI., 1984) . This method makes a number of assumptions beyond the usual compartmental assum ptions. These include the fo llowing: (a) Only unbound tracer in the plasma can cross the BBB. (b) Trans port of unbound tracer across the BBB is bidirec tional and occurs by passive diffusion. (c) Only free 1986 ligand within the extravascular space is available to bind to specifi c receptors ; i.e., nonspecifically bound ligand is not available for specific binding. (d) Free and nonspecifi cally bound tracer in the vascular and extravascular spaces is essentially in equilibrium at all times. As free radioligand crosses the BBB or binds to specific sites, the equilibria shift so that the relative proportionsfl andf2 of free and nonspecifically bound radioligand remain con stant throughout the length of each study. (e) Fur thermore, f2 is the same in different regions of the brain, and specifically is the same in striatum and cerebellum. (f) Association of ligand and receptor fo llows bimolecular kinetics and dissociation fo llows unimolecular kinetics. (g) The receptor sites are not saturated by the tracer. (h) The radio tracer is not metabolized within the time of the PET study.
The se assumptions have been addressed pre viously (Mintun et aI., 1984) except for the last. We have fo und that labeled metabolites of [18F]spiro peridol quickly appear in the blood ; however, re cent evidence suggests that these do not cross the BBB, and moreover that there is minimal metabo lism of [18F]spiroperidol by brain tissue itself (Ar nett et aI ., 1985) . Therefore, differential equations of the model must be modified to account for the time-dependent fraction of intravascular activity that represents labeled metabolites (Appendix A) .
Given the above assumptions and the resulting set of differential equations describing this model (equation set Al in Appendix A) , fi ve parameters (defined in Ta ble 1) remain to be estimated: the fraction of tracer in compartment 2 free to bind to receptors (f 2)' the fo rward rate constant for specific binding (kl), the brain permeability -surface area product for the ligand (PS) , the maximum concen tration of radioligand receptor sites (Bmax), and the ligand-receptor dissociation rate constant (k -I)'
All of the others are directly measured during the PET study or obtained during the same study ses sion as independent measurements (e .g., regional blood flow F and blood volume VI)' Additionally, V2 and V3 (i.e., the volumes of compartments 2 and 3) are both assumed to be equal to the brain tissue water space, which is known independently. For an area devoid of specific dopaminergic receptors (e.g., cerebellum), kl' Bmax, and k_1 are zero , leaving only two parameters , f2 and PS, to be esti mated. The value of f2 fo und for the cerebellar re gion then can be applied to any other brain region (e. g., striatum), thereby reducing the number of un known parameters there to four. Because kl and Bmax cannot be uniquely estimated (Appendix A) , 
Maximum tracer specific binding concentration
Tracer fraction free from nonspecific binding in compartment i
Regional blood flow
Tracer permeability of the blood-brain barrier x capillary surface area Both the explicit (Mintun et aI., 1984) and the ratio (Wong et aI., 1984) methods are based upon the same three-compartment model .
Rate constants in compartmental analysis are conventionally denoted by lower-case k's as described in the text, but we will use upper-case K's when referring to rate constants in the ratio method as this was the notation originally proposed (Wong et aI., 1984) .
Further details concerning symbolism and specifically the definition of K are given in Appendix C.
a Operationally, a total tissue volume of 1.0 ml is assumed for estimation of parameter values with the explicit method. b c p represents tracer content in the intravascular space, ce is the content of tracer free from specific binding in the extravascular space, and cr is the content of tracer bound to specific sites in the extravascular space.
Eqs. Al contain the parameter k l " which is actu ally k l Bmax' Thus, only three unknown parameters, P S, kl" k -I' remain in the set of differential equa tions applied to the striatum (Eqs. AI). These equations can be integrated analytically or numeri cally. Values of the three parameters can be esti mated using the integrated equations and inde pendent measurements of regional blood flow, blood volume,! l , cerebellar 12' serial measurements of total radioactivity and radioactivity due to [l8F]spiroperidol in the blood as well as striatal tissue radioactivity obtained using PET.
Ratio method. Notation for the ratio method pro posed by Wong et al. (1984) is shown also in Table  1 . Rate constants in compartmental analysis are conventionally denoted by lower-case k ' s as de-scribed above, but we will use upper-case K ' s when referring to rate constants in the ratio method , as this was the notation originally proposed (Wong et aI ., 1984) . This method, again, is based on the three-compartment model depicted in Fig. I . How ever, these authors made many additional explicit and implicit assumptions to simplify the differential conservation equations for that model. They explic itly assume the following: (a) Extravascular ligand returns to the intravascular space much faster than it binds to receptor (i.e., K2 � K3)' (b) The dissocia tion rate of ligand from receptor is negligible (i.e., K 4 = 0). (c) All extravascular ligand, including non specifically bound ligand, is available to bind with receptor (i.e' ' /2 = 1). The ratio approach implicitly assumes the following: (a) The intravascular tracer activity is negligible in comparison with the extra vascular activity so that regional cerebral blooo volume need not be measured. (b) Differences in regional blood flow in an area of interest (e. g., striatum) compared with that of the reference re gion devoid of specific binding sites (e. g., cere bellum) have no appreciable effect on tracer distri bution and therefore need not be considered. (c) Regional BBB permeability and capillary surface area are constant throughout the brain such that differential regional uptake reflects differences in specific binding alone and is not influenced by any regional permeability or capillary surface area dif ferences (i.e., Kl and K2 are identical in striatum and cerebellum) (Appendix B). (d) The entire his tory of the plasma content of tracer is either con stant or can be approximated by a power function, and the initial peak in the plasma activity curve does not contribute substantially to the total dose delivered to a region of interest from the time of tracer injection to time T (such that T � IIK2) (Ap pendix B). (e) Labeled metabolites of the tracer ei ther do not exist in the blood or brain during the PET study or, if they do exist in the blood, they do not cross the BBB. As with the explicit method, we find it necessary to appropriately correct our com putations using the ratio method for labeled metab olites accumulating within the intravascular com partment. However, it should be noted that the la beled metabolites of [18F ]spiroperidol and [ ll C]N-methylspiroperidol could be very different.
The differential equation set that describes tracer conservation for the three-compartment model (Appendix A) is easily modified for the ratio ap proach (Appendix B). The resulting set of differen tial equations can be integrated analytically. Fur ther simplifications of these solutions based on the above assumptions are detailed in Appendix B. 1986 of the ratio of tissue radioactivities for the striatum and cerebellum and the blood radioactivity.
What is the evidence supporting the assumptions of the ratio approach? Wong et al. (1984) demon strated that the striatal-to-cerebellar tissue activity curve was linear with respect to time and stated that "this linearity also confirms that K 4 � K3; therefore, we set K 4 = 0." It was argued that "the normalized integral [(JbCA(t)dt)lcA(T)] becomes proportional to time; hence, the model predicts a linear increase in AcalAcb with time as observed ex perimentally, with a slope determined by K3 ... [and this] ... indicates that measurement of cere bral blood flow and volume is not required." (Aca is the radioactivity in the caudate, a part of the striatum; Acb is cerebellar activity.) Preliminary evi dence for the validity of these assumptions was provided by showing that the slope of the plot for the ratio of striatal to cerebellar tissue radioactiv ities versus time decreased with increasing age for normal subjects. This agrees qualitatively with au topsy studies that demonstrate decreasing dopami nergic receptors with age . The validity of these as sumptions is discussed more extensively below.
METHODS
Six separate PET studies were done on a single fe male baboon weighing 10 kg . Blood metabolites of [18F]spiro peridol were measured in only three of these studies (see fo llowing text) . For all studies, the animal initially was anesthetized with 10-15 mg/kg i.m. of ketamine, para lyzed with 2-4 mg/kg i.v. of gallamine, intubated with a soft-cuffed endotracheal tube, and ventilated with 70% nitrous oxide and 30% oxygen. A 20-gauge plastic cath eter was inserted into a fe moral artery to permit arterial blood sampling, and a similar catheter was placed into an arm vein for the administration of radiotracer. Blood pressure and pulse were monitored throughout the study. Frequent arterial blood gases measurement confirmed that Pcoz and POz were constant throughout the proce· dure.
All PET studies were performed with the PETT VI system (Ter-Pogossian et aI., 1982; Yamamoto et aI ., 1982) . Data were recorded simultaneously for seven "slices" with a center-to-center separation of 14 .4 mm. Studies were done in the low-resolution mode, yielding an in-plane (i.e., transverse) reconstructed resolution of � 14 mm in the center of the field of view and an axial resolution of � 14 mm at the center. After each scan, the baboon was moved 7.2 mm axially and the scan was re peated. This yielded a total of 14 interleaved slices each 7.2 mm apart . The head of the baboon was positioned with the aid of a vertical line projected from a laser permanently fixed on the wall . The line coincided with the center of the lowest PET slice when the scanning table was completely advanced into the scanner. The head was firmly clamped in place using a modified stereotaxic head holder with mouth and ear bars. A lateral skull radiograph with the position of the lowest slice marked by a radiopaque wire provided a permanent record of the animal's position within the scanner. Both the lateral skull radiograph and the modified stereotaxic head holder allowed precise re positioning of the animal for repeated studies.
Attenuation characteristics of the head were deter mined individually prior to each study by obtaining a transmission scan using a ring source of germanium-68gallium-68. Cerebral blood volume was determined fo l lowing the inhalation of ISO-labeled carbon monoxide and a 5-min PET scan as described by Grubb et a!. (1978) . CBF was estimated using a 40-s scan after the intrave nous injection of 20-30 mCi of 150-labeled water (Her scovitch et a!. , 1983; . The free fraction of tracer in blood fl was determined by the addition of [18F]spiroperidol to an arterial plasma sample (0. 5 ml) fo llowed by ultracentrifugal microfiltra tion (Whitlam and Brown , 1981) . The fraction of radioac tivity that passed through the filter (i.e. , not protein bound or trapped) represented the free fraction. At least 2 h after the induction of anesthesia, 3-6 mCi of carrier added [ISF]spiroperidol (specific activity 10-30 Ci/mmol) in 3-5 ml of normal saline was intravenously injected over 30-45 s. This was prepared on site as previously described (Kilbourn et al. , 1984) . Sequential PET scans were started immediately with the intravenous injection of tracer and were continued repeatedly for � 3 h. Scan durations were 2 min initially; longer scans (up to 20 min) were required at the end of the study to maintain coinci dence counts above 200 ,000 per slice. The midpoint of each scan was recorded as the time elapsed fr om the start of tracer injection.
Arterial blood samples (0. 3 ml) were collected every 3-5 s for the fi rst 60-120 s and then with decreasing fre quency to every 5-10 min during the remainder of the study. The high sampling frequency initially used in re cording the blood radioactivity history was necessary to ensure a temporal resolution adequate to accurately de fine the peak value. For two control studies and one pre treatment (0. 2 mg/kg) study (see fo llowing text) , periodic arterial plasma samples al so were analyzed to measure the percentage of total radioactivity present as [18F]spiro peridoi. These plasma samples were made basic (pH> 8) and extracted twice with organic solvents (1: 1 by vol chloroform-ethanol). The organic extracts were ana lyzed by thin-layer chromatography (silica gel , 30:9: 1 chloroform-methanol-water) as previously described (Arnett et a!. , 1985) . The remaining 18F radioactivity rep resented the fr action of unmetabolized ligand in the plasma sample.
Two control studies (no pretreatment with unlabeled spiroperidol) were interspersed among fo ur experiments using pretreatment with unlabeled spiroperidol (0.35, 0. 52, 0. 1, and 0. 2 mg/kg) to monitor any changes in re ceptor binding that might have occurred as a result of spiroperidol injections. Unlabeled spiroperidol was in jected intravenously over 3-5 min �60 min prior to [18F]spiroperidoi. Blood pressure and pulse were moni tored during the injection. Studies were at least 3 weeks apart to allow sufficient time for animal recovery.
Ratios of striatal to cerebellar radioactivity versus time were evaluated for all six studies. For the studies that had measurements of blood metabolites of [18F]spiroperidol [i.e. , two control and one pretreatment (0. 2 mg/kg) studies], the fo llowing also were evaluated. "Normalized integrals" of total radioactivity in the blood as well as of radioactivity due to [l8F]spiroperidol [i. e. , (J'{;c A(t)dt)/ cA(D] (Appendix B) were calculated and plotted versus time. The "normalized integrals" were calculated in parts. The initial rise, the subsequent rapid decline, and the remaining more slowly declining part of each blood activity curve were individually approximated using ei ther power fu nctions or single exponentials. These three fu nctions were integrated analytically and their sum rep resented the entire integration of the blood activity fr om time 0 to T. K3 was determined with the ratio method for these three experiments using both the metabolite-cor rected and uncorrected blood radioactivity curves. K3 was calculated by substituting time-dependent values for the "normalized integral" and ratio of striatal to cere bellar tissue activities into Eq. Bll. Alternatively, K3 could be estimated graphically by determining the slope of a plot of the ratio of striatal to cerebellar radioactivities versus the "normalized integral" (Fig. 6 ) , but we did not use this method.
The explicit method both with and without correction for tracer metabolism also was used to calculate the best estimates of the model parameters for these three experi ments. Parameter estimation was accomplished using a modification of Marquardt's algorithm (1963) fo r weighted nonlinear least-squares approximation. Simple equations relating the changes in each parameter value to changes in the residue curve were derived from sensi tivity analyses. For example, the variable PS affects pre dominantly the early part of the residue curve, whereas other variables influence the later part. These simple re lationships were used in the initial iterations of the Mar quardt algorithm to provide adequate early estimates of parameter values. This procedure expedites the estima tion algorithm.
RESULTS
Time-activity curves fo r total 18F and fo r [18F]spiroperidol in arterial blood for a control study are shown in Fig. 2 . About 30 min after the intravenous injection of [18F]spiroperidol, more than half of the 18F activity in plasma was due to labeled metabolites. The concentration of [18F]spi roperidol continued to decrease during the entire 3-h study (Fig. 2) .
Values of f2' PS, k_ I ' and k l ' were estimated using the explicit approach only for the studies in which plasma metabolites of [18F]spiroperidol were measured ( Table 2 ). The correction for metabolites altered the values of k l ' for each experiment com pared with values obtained using uncorrected data. The value of k l ' decreased after the baboon was pretreated with 0.2 mg/kg unlabeled spiroperidol. Notably, the dissociation rate constant k_ 1 was not zero in either the control or the pretreatment studies.
Both striatal-to-cerebellar ratios of tissue activity and the "normalized integral" of the blood activity need to be evaluated to calculate K 3 with the ratio method. To examine the behavior of the striatal-to cerebellar ratios and the "normalized integrals," each was plotted versus time after [18F]spiroperidol injection into control and pretreated baboons. As predicted by the ratio method, plots of striatal-to cerebellar ratios versus time were linear for control and pretreatment studies (Fig. 3) . Furthermore, the slopes of the ratio curves decreased after pretreat ment with unlabeled spiroperidol . For both the control and the pretreatment studies, the "normal ized integrals" of the blood radioactivity were not linear with respect to time (Fig. 4) . Contrary to the assumptions in the ratio method, estimates of K 3
varied with time after [ISF]spiroperidol injection, even at early times when the "normalized integral" appeared linear (Fig. 5) . In both the control and the pretreatment studies, the value of K 3 first increased and then began to decrease between 75 and 90 min after tracer injection without achieving a constant value . The value of K 3 at 45 -55 min after tracer injection calculated using the ratio method for each experiment and the corresponding values estimated with the explicit method are listed in Ta ble 2. Com parisons of corresponding values are facilitated by expressing parameters in conventional compart mental notation using the equivalence expressions delineated in Ta ble 1. For example, k32 (conven tional notation) is equivalent to K 3 (ratio notation) and to k l'f2 (explicit notation) ( Table 1) . For the first control study, the explicit method estimated k32 as 6.3 x 10-4 s -I , whereas the ratio method esti mated k32 as 4.4 x 10-5 S-I.
DISCUSSION
As we have emphasized, both the explicit and the ratio methods for in vivo measurement of dopami nergic binding are based upon the same three-com partment model. Nevertheless, there are large dif ferences between values for corresponding rate constants calculated from the same PET data using the two methods. Comparisons of corresponding values were hampered by the difficulty in calcu lating K 3, the specific rate constant of the ratio model that is used to describe receptor binding. Since it is defined as a rate constant, K 3 should re main invariant over the duration of the study. It was found, however, that the value of K 3 calculated with the ratio method depends upon the time k.' k. 'f2 K 3
Control 1 No 0.043 0.042 8.6 x 10-4 J.5 x 10-2 1.7 x 10-4 5.1 X 10-5
Yes 0.046 0.020 2.1 x 10-4 8.6 X 10-3 6.3 X 10-4 4.4 X 10-5 0.2 mg/kg spiroperidol No 0.138 0.016 4.0 x 10-3 5.8 X 10-2 9.3 X 10-4 2.8 X 10-5
Yes 0.132 0.0042 9.6 x 10-7 2.5 X 10-3 1.0 X 10-5 2.1 X 10-5
Control 2 No 0.033 0.033 3.9 x 10-4 6.2 X 10-3 2.0 X 10-4 2.7 X 10-5
Yes 0.031 0.016 1.9 x 10-4 8.5 X 10-3 1.4 X 10-4 1.8 X 10-5
The data for these analyses come from three positron emission tomographic studies performed on the same baboon. Amounts of .8F radioactivity in arterial blood samples drawn after the intravenous injection of [I8F]spiroperidol were corrected for time-dependent concentrations of labeled metabolites for these three studies. Values were estimated for each study both with and without this correction for tracer metabolism. Units for each of the variables are listed in Table I . Value of K 3 was estimated using the ratio method at 45-55 min after tracer injection. Values for K 3 (using the ratio method) can be compared directly with values of k.'/ 2 (determined with the explicit method) since these are equivalent terms ( Table I ; Appendix C). Explicit method requires three supplied parameter values (f., F, V.) that are measured independently as described in Methods. For the three studies, values for I. are 0.060, 0.040, and 0.044, respectively; for F (regional blood flow) 0.0088, 0.0071, 0.0041 mils; and for V. (regional blood volume) 0.037,0.030, and 0.043 m\. Each line represents the ratios of the striatal to cere bellar tissue radioactivities measured at different times for as long as 3 h after the intravenous injection of [1BF]spiroper idol into a baboon. Unlabeled spiroperidol was intravenously injected -60 min prior to tracer. Control animal had no pre treatment. All studies were done in the same baboon. This demonstrates that the plots of the ratios versus time are linear for control and pretreatment studies. These plots were not used to calculate radioligand binding.
chosen to make the calculation (Fig. 5) . The expla nation for this inconsistency with the ratio method and for the discrepancies between corresponding values estimated using the ratio and explicit methods is that the two methods of analysis have different underlying assumptions. A review of the validity of these assumptions suggests several pos-20. . the rate constant of the ratio method that describes receptor binding) were calculated using Eq. B1 1 at various times after the intravenous injection of [1BF]spiroperidol for the control study and after pretreat ment with unlabeled spiroperidol (0.2 mg/kg). These data demonstrate that for both the control and the pretreatment studies. the values of K3 first increased and after 75-90 min began to decline without approaching a constant value. Both studies were performed in the same baboon. sible errors in the ratio approach that contribute to the difficulties in its application.
The effects of tracer metabolism will be dis cussed first since both proposed methods assume that there was no metabolism during the time re quired for a PET study. Both the data presented here and those of past studies (Arnett et al., 1985) demonstrate this assumption to be wrong for [l8F]spiroperidol. Fortunately, the labeled metabo lites do not accumulate within the cerebral extra vascular space (Arnett et al., 1985) ; this made it possible to modify both methods by assuming that these metabolites remain in the intravascular com partment (Appendix A). Our introduction of this modification had a marked effect upon the values of the calculated parameters of the explicit method ( Table 2 ). The ratio method was modified to correct for tracer metabolism by using the blood activity term C A (t) in Eq. B 11 to represent only true [ l 8F]spiroperidol and not CT(t), which is the total 18F activity. This alteration decreased by 20% the value of K 3 calculated with this method (Table 2) . It is important to note that by itself this particular modification of the ratio method might not suffice to improve its performance when [ 1 1C]N-methyl spiroperidol is used as the tracer if labeled metabo lites (such as [ l lC]methanol) are found to be present in the extravascular space of the brain. A labeled metabolite that has a high extraction frac tion would distribute throughout the brain in a manner dependent upon regional blood flow and brain permeability (PS). If these parameters varied between the two regions chosen fo r the ratio method (e.g., striatum and cerebellum) , then the ratio of regional uptake of total radioactivity would be affected. Both methods are sensitive to errors due to the accumulation of metabolites as evi denced by the changes in values of the parameter estimates fo und after correcting the blood activity curves (Table 2) . Nevertheless, correction for tracer metabolism fa iled to bring the two methods into agreement.
The ratio method proposes that measurements must occur at least at time T, such that T � IIK2• For the control study depicted in Figs. 2-5, the value of 11 K2 (K2 = 12P SIV2) (Table 1) is -14 min (values for 12 and PS are in Ta ble 2, control l). Nev ertheless , the value of K3 calculated between 40 and 60 min after tracer injection (a constraint im posed by the half-life of carbon-II used to label tracers such as N-methylspiroperidol) was -40% lower than the value calculated at 90 min after in jection. At 40-60 min the values of K3 for the con trol and pretreatment studies were indistinguish able. Wong et ai. (1984) argue that the "normalized integral" of the blood activity curve [i.e., (f[;cA(t)dt)lcA (1)] is linear with respect to time and that this would ensure that the slope of the ratio of striatal to cerebellar tissue activities would "re flect" K3• At these early times, the initial peak of the blood activity curve contributes substantially to the total exposure of the tissue to tracer. Since the entire history of the arterial blood concentration of unmetabolized tracer cannot be estimated during this time as a constant or a power fu nction (a tacit assumption of the ratio method) (Appendix B), the "normalized integral" is nottruly linear and appli cation of the ratio method fails. This explains in part the rapidly changing values for K3 calculated at these early times after tracer injection.
The ratio method also assumes that the receptor dissociation rate constant K4 is negligible (i.e., K4 «i K3)' We have estimated this rate constant using the explicit method and fo und it to be nonzero for both the untreated and the pretreated baboons (Table 2) . For both studies, the value of K3 first rises and then falls 75-90 min after tracer injection (Fig. 5) . The decline in the later values calculated for K3 probably reflects in part the influence of a nonzero dissociation rate constant k23 (i.e., K4 in ratio method notation). Wong et ai. (1984) argue that the linearity of the striatal-to-cerebellar tissue activity ratio versus time confirms that K4 is negli gible (i.e., k23 «i kd. This is not supported by our data. Although the plot of striatal to cerebellar tissue activity versus time appears linear (Fig. 3) , the nonlinearity of the ratio-versus-"normalized in- Vol, 6, No, 2, 1986 tegral" graph ( Fig. 6) suggests that dissociation of tracer fr om specific binding sites is important (Patlak et aI., 1983) . In addition, k23 estimated by the explicit method is not negligible. Thus, dissoci ation from specific binding sites cannot be ne glected when using [ l 8F]spiroperidol as the radioli gand.
The validity of other assumptions of the ratio method is supported by our data: (a) K3 (i.e., k32) is much less than K2 (i.e., k 12) as evidenced by the data in Ta ble 2. (b) The intravascular compartment contributes a negligible amount of activity within the field of view of the PET. In both control and pretreatment studies, the contribution from the in travascular compartment has decreased to 4% of the total brain radioactivity by 6 min after injection. (c) Previously reported simulation studies confirm that the parameter estimation is insensitive to errors in regional blood flow (Mintun et aI., 1984) .
The ratio method could be employed for the anal ysis of PET data obtained after the intravenous in jection of a radiolabeled ligand that satisfied several criteria in addition to those delineated in the intro ductory section. The radioligand must be irrever sibly bound to receptors (i.e., k23 should be zero). The tracer should not have labeled metabolites that accumulate within the extravascular space of the brain. The entire history of the arterial blood con tent of unmetabolized tracer must either be con stant or able to be represented by a power function (Appendix B). Finally, the rate constant for passage Values of the ratio of striatal to cerebellar tissue ac tivities are plotted versus the "normalized integrals." Ac cording to the ratio method, these plots should be linear if radioligand binding is irreversible and then the slopes equal to a measure of receptor binding, K3. These plots are not linear and demonstrate that the ratio method cannot be em ployed to calculate K3 when [18Flspiroperidol is the radioli gand. Both stUdies were performed in the same baboon.
of tracer from the intravascular space to the extra vascular tissue must be the same in the receptor rich and receptor-poor tissues (i. e., k2 l should be constant throughout the brain) . It is important to realize that even if these criteria are satisfied, the ratio method calculates a value that represents the product of three factors: the fo rward rate constant (i.e., k 1 ), the maximum receptor concentration (i.e., Bm ax ) , and the fraction of tracer in the extra vascular space available for binding to receptors and not nonspecifically bound (i.e.,j2)' Only if the above criteria are fulfilled and 12 is constant among different subjects and does not change for patholog ical conditions will comparisons of values for this rate constant (i.e., K 3 or k32) obtained with the ratio method be meaningful.
The explicit method also has several limitations. Estimates of values of rate constants are sensitive to errors in P Sand 12 (Mintun et aI. , 1984) . The values of the individual rate constants also depend upon the value chosen for the volume of distribu tion of the tracer in the extravascular space (V2) . In these studies, the volume of distribution of water was assumed to be equal to the volume of distribu tion of the tracer, but this has not been proven. Fi nally, the explicit method assumes that receptors are not saturated by the radiotracer. This should be true for high-specific activity preparations of [ l BF]spiroperidol for which the total injected dose of spiroperidol would be 10-20 f,Lg (Kilbourn et aI . , 1984) . This is well below the dose demonstrated to have clinical effects on schizophrenic individuals (Mattke, 1968 ) and reasonably may be assumed not to saturate receptors. This, however, also has not been proven and has not been studied in patients with other neurological or psychiatric diseases thought to involve dopaminergic receptors.
SUMMARY AND CONCLUSIONS
We have pointed out that the same three-com partment model forms the basis for the two appar ently different methods proposed for measuring re ceptor binding in vivo with PET. The two methods differ in the assumptions necessary for practical implementation. When both approaches are applied to the same PET data, disparate values for corre sponding parameters are obtained. Some of the as sumptions required for the development and imple mentation of the ratio method appear to be invalid and lead to inconsistencies in the resulting calcula tions. Most importantly, we have found that the magnitude of the dissociation rate constant from receptor, k23, appears, on the basis of the complete, unsimplified model, to be appreciable and that the entire history of the time-activity curve for the un metabolized radiotracer is not constant nor can it be represented by a power function. We have shown tracer metabolism to be an important factor that must be considered in the formulation of re ceptor models. Of course , we obtained our data from experiments using [ l BF]spiroperidol as the ra diotracer and not [lIC]N-methylspiroperidol for which the ratio method was proposed. Labeled me tabolites of [lBF]spiroperidol do not accumulate in the brain (Arnett et aI . , 1985) . Exclusion of labeled metabolites from brain tissue has not been demon strated fo r [llC]N-methylspiroperidol . At this point, neither approach has been validated by com parison with independent measurements. The ratio method, however, exhibits several internal incon sistencies that seem to cast doubt on its validity at least when applied to data obtained using [ l BF]spi roperidol as the radioligand. Our results indicate that the adoption of simplifying assumptions for op erational convenience can lead to substantial errors and must be done with caution. Moreover, our in troduction of the analytical solutions of the tracer conservation equations describing the complete, un simplified three-compartment model vastly re duces the computations needed to implement the explicit method, thus making unnecessary the sim plifications of the ratio method.
APPENDIX A Explicit method
We provide here the results of our derivations of the simulated residue functions we used in imple menting the explicit approach to process our PET scan data for estimating the various transport and reaction rate parameters . Further details con cerning compartmental models are available in Jac quez (1972) and Godfrey (1983) . We note that our compartmental models pertain to the behavior of tracer only in a single capillary-tissue system, which represents an averaged tracer behavior in a region comprising a large number of such capil lary-tissue systems. Such being the case , our models cannot reflect the effects of morphological and biochemical heterogeneities in a region defined by the resolution capabilities of present emission tomographs.
On the basis of the assumptions discussed in the text, tracer conservation conditions for the three compartment model appropriate for [ISF] spiroper idol in striatum are as follow:
the asterisk denotes the convolution operation. I In Eq. A4, the (X i are the three roots of the cubic equa tion
In Eq. Ala, the factor ret) represents the fraction of inflowing t8F that is present as unmetabolized [ l sF]spiroperidol at time t after the start of tracer injection; CT(t) is the total t8F concentration in the arterial inflow. Overdots denote ordinary derivates with respect to time. The parameter kl' in Eqs. Alb and Alc is a composite defined by Mintun et al . (1984) as kt' = ktBma X ' All time-varying tracer quantities and time-invariant parameters in Eqs. Al are defined and discussed in the text.
In terms of the convenient notation used almost universally in compartmental analysis (Jacquez, 1972; Godfrey, 1983) , Eq . Al take the form
Defined in this way, the turnover rate constants kij in the above equations represent, for i =ft j, the frac tion of tracer in compartmentj transported per unit time into compartment i. For i = j, the constants are defined as kll = kO I + k21 and k22 = k12 + k32• The model residue function for [ISF]spiroperidol in striatum is given by
where [qP)]] = I is the solution set of Eqs. Al or A2, given the initial conditions q/O) = 0, j = 1,2,3. The subscripted B in the above denotes a region of in terest in which specific binding sites are present (e.g., striatum) . In terms of the model parameters, the residue function for these initial conditions is where 3 qB(t) = <Ps(t) * 2: Aie-a,1
is the local unmetabolized [tSF]spiroperidol con vective flux into the striatal region of interest and 
where
For physiologically plausible values of the kij' these roots are real, positive, and distinct. The coeffi cients Ai' i = 1,2,3, in Eq. A4 are given by
In Eq s. A 7, the coefficients in the numerator are given by
and For [tSF]spiroperidol in cerebellum, where spe cific binding sites are absent, kt ' = 0, and the three-compartment model (Eqs. Ala-c) reduces to one having only two compartments. In principle, it would be possible to use, for cerebellum, the above three-compartment solutions evaluated for k23 = 0 and V3 = O. In practice, this has the potential for large numerical errors because of finite word length effects in the digital computer implementation of Eqs. A6 and A7. Therefore, to simulate the residue function in cerebellum, it is safer to use ab initio the two-compartment model whose tracer conservation conditions are (A8a) (A8b) In Eqs. A8a,b the symbols all have the same meanings as in Eqs. A2a-c. The model residue function for unmetabolized tracer in cerebellum is 2
where {q l (t), qz{t)} is the solution set for Eqs. A8a,b given the initial conditions q/O) = 0, j = 1,2 (Jac quez, 1972; Godfrey, 1983; Tilton et aI., 1983) , and where the subscripted B denotes a region of in terest in which specific binding sites are absent (e.g., cerebellum). In terms of the model param eters, the residue function Eq. A9 is 2 q13(t) = <ps(t) * 2: B;e -13;t
where <Ps(t), the local labeled spiroperidol flux into the cerebellar region of interest, is given by Eq. AS with blood flow F13 independently evaluated for that region. In Eq. AI0, the 13; are the two roots of the quadratic equation Since ISF-labeled metabolites of [ 1 sF]spiroperidol do not cross the BBB, the residue function for these corresponds merely to that for the vascular compartments of the above two-and three-com partment models. Therefore, metabolite conserva tion within a region of interest is expressed by In the above, the parameter ko A is defined as in Eqs. A2a and A8a. (Recall that kll = k OI + k21 .) In terms of physiological parameters, it is given by k OI = FIV 1 • In the explicit method, both blood flow F and blood volume V I are measured locally for striatum and for cerebellum; thus, the value of the param eter k O I is also a local value. In the ratio method, both F and V I are assumed to be the same for both regions. The solution of Eq. A12 (Jacquez, 1972 ; Godfrey, 1983) is
is the flux of ISF-Iabeled metabolites into the region of interest and where the subscripted M denotes the labeled metabolites. The complete residue function for a region of in terest is the sum of the residue functions for unme tabolized [ISF]spiroperidol and for its ISF-Iabeled metabolites. Thus, we have for striatum This concludes our brief description of the ana lytical, closed-form residue function used in our implementation of the explicit method for measure ment of receptor binding.
APPENDIX B

Ratio method
The ratio method (Wong et aI. , 1984) requires a PET scanner to obtain residue histories of radio tracer in (a) the striatum, a region rich in dopami nergic receptors, and (b) the cerebellum, a region that is not, and then, from the ratio of the two histo ries, inferring values of the forward ligand-re ceptor reaction rate constant in the striatum. To make the method useful for analysis of PET data using easy hand calculations, Wong et ai. have in troduced a number of simplifying assumptions in the solutions of the equations of the three-compart ment model that is the basis of their method. This is the same compartmental model that underlies the explicit method as well. The assumptions basic to this model are discussed in the text; solutions of the differential equations describing tracer conserva tion are given in Appendix A.
To clarify the effects of the various modifications introduced by Wong et al. (1984) , we begin by writing the full expression for their residue history ratio in terms of the complete solutions given in Appendix A. We then simplify this expression step wise, introducing their approximations, both stated and tacit, until we arrive at the equation they use in interpreting their PET data.
The rigorous (within the framework of the three compartment fo rmulation) expression for the ratio of Wong et al. is obtained by combining Eqs. AI5 and AI6 in the form
where the local residue functions are given by ap propriate evaluation of Eqs. A4 , AlD, and Al3. In the above, it is supposed that the tracer quantities have been normalized to the volume of the voxel of interest.
We now proceed to apply the assumptions of Wong et al. to Eq. Bl. First, they assume (tacitly) that labeled metabolites of tracer do not appear in blood, or if they do exist they do not cross the BBB. Thus, if labeled metabolites do not appear, ret) ::= 1 and qm(t) ::= 0 for t � 0, and, recalling Eqs.
A3 and A9, Eq. B 1 becomes where fit) is any function of time; that is, the result of a convolution of o C t) with fit) is to leave fit) un changed. Identifying fit) with q,(t) or with its inte gral in Eq. B8, we obtain the approximation f q,(T)dT
ql(t)
In compartmental notation, the above is the equa tion given by Wong et al. (1984) by which they pro pose to analyze their tomographic and serial blood sample data to obtain estimates of k32' the forward ligand-receptor reaction rate constant in the striatum. We note that Wong et al. specify the plasma content of tracer in their derivations, while Eq. B9 incorporates the whole-blood content q,(t).
Implicit in any compartmental model in which blood is taken to be a single compartment is the as sumption either that tracer is confined to plasma or that it is freely diffusible across red blood cell membranes. Therefore, the distinction between plasma and whole-blood contents if of no conse-quence for Eq . B9, since the proportionality con stant relating the two (see Eq. C16) cancels in the numerator and denominator. Operationally, how ever, Eq . B9 cannot be implemented since neither the radioligand content of compartment l, q , (t) , nor its concentration, c l (t) , can be directly measured. Thus, to implement the ratio method, it is neces sary to introduce one final approximation in addi tion to those of Wong et al . This is expressed by
where C A(t) = cT(t)r(t) . We note that this is tanta mount to assuming a zero extraction of tracer fr om blood into tissue across the BBB. This assumption, of course , may be grossly erroneous. We accept it nevertheless, since the alternative would imply in ability to use the ratio method at all . Note also that with the explicit method, based on rigorous solu tion of the three-compartment equations Al or A2 , it is not necessary to make the approximation ex pressed in Eq . B 10.
To permit an implementation of the ratio method , we insert Eq. B 10 into B9 and solve for k2 3, ob taining
The above is an implementable expression that can yield values for the receptor binding rate constant kd = K3 of Wong et aI .). Note that the denominator is the "normalized integral" of the time-activity curve for tracer.
This concludes our brief description of the ratio method of Wong et al . (1984) . Our equations pro vide the basis for the notation equivalences given in Appendix C.
APPENDIX C Notation equivalences
To facilitate intercomparison between the explicit and the ratio methods for assessing dopaminergic binding in brain using PET, we establish and pro vide here explicit correspondences between the no tations used by Mintun et al . (1984) and by Wong et al . (1984) . With the intent of encouraging use of a common symbolism for future studies, we show the interrelations between the notations of the explicit and of the ratio methods, and relate both to the al most universally employed notation of compart mental analysis (Jacquez, 1972; Godfrey, 1983) .
To establish the correspondences, we compare , term by term, coefficients of like tracer flux terms in the equations expressing tracer mass conserva tion conditions for the compartmental model that is the basis for the three formulations. We note that for this purpose the conservation conditions must be expressed in terms of total tracer quantities, and not in terms of concentrations, because the prin ciple of conservation of mass applies only to the fo rmer. The connection between concentrations and quantities is simple for compartmental models because of the basic compartmental assumption that spatial concentration gradients within a com partment are flat. This assumption is expressed as
Exp licit versus compartmental notations. Using Eq . CI in Eqs. Al and comparing the result term by term with A2, we can immediately write down tracer quantities in terms of concentrations and volume and the k ij in terms of the physiological pa rameters. The correspondences are , for tracer quantities and concentrations, In our experiments, we independently measure F, VI ' and fl ' and assume V 2 is the same as brain tissue water space. We further assume that V 3 = V 2 • The explicit method allows estimation of the re maining physiological parameters from the data. These are PS, f2 ' k, ' , and L, (Mintun et aI ., 1984) . In terms of the compartmental turnover rate con stants and the measured parameters, the remaining physiological and biochemical parameters are Ratio versus compartmental nota tions. In Ap pendix B, we wrote the equations for the ratio method in terms of compartmental notation. Here we give equivalences between the notation of Wong et al . (1984) 
In the above, subscripted B and B denote, as be fo re , regions where specific binding sites are present or absent , respectively. In Eq. C16, the factor K accounts fo r differences between the plasma content of tracer, as specified by Wong et aI ., and the radioligand content of whole blood used in the explicit and compartmental models. This factor can be shown to be given by
where H is the small-vessel hematocrit and fL = tracer concentration in red blood cells tracer concentration in plasma fL expresses the distribution of radioligand between plasma and red blood cells. Recall that Aca repre sents the radioactivity in the caudate, a specific re gion of the striatum. We derive relations between the turnover rate constants by equating terms in the two notations expressing the same unidirectional tracer fluxes, yielding 
The interrelations derived in this appendix are summarized in Table 1 of the text.
